Skip to main content

Table 4 Independent predictors of reintervention

From: Influence of preprocedural glycemic control on clinical outcomes of endovascular therapy in diabetic patients with lower extremity artery disease: an analysis from a Korean multicenter retrospective registry cohort

 

Univariable analysis

Multivariable analysis

HR

95% CI

P-value

HR

95% CI

P-value

Age (per 10 years)

0.963

0.790–1.174

0.709

   

Sex (female)

1.018

0.816–1.271

0.872

   

Low BMI (< 18.5 kg/m2)

1.445

0.674–3.098

0.344

   

Hypertension

0.740

0.502–1.091

0.128

0.767

0.516–1.140

0.189

Use of insulin

1.394

0.978–1.987

0.066

1.147

0.789–1.668

0.472

Hypercholesterolemia

1.182

0.834–1.675

0.346

   

End-stage renal disease

1.725

1.095–2.718

0.019

1.719

1.074–2.753

0.024

Congestive heart failure

1.225

0.598–2.506

0.579

   

Current smoker

0.899

0.607–1.330

0.593

   

Coronary artery disease

0.699

0.495–0.987

0.042

0.863

0.584–1.274

0.458

Previous history of stroke

1.023

0.646–1.618

0.924

   

Previous history of bypass surgery

1.846

0.754–4.518

0.180

1.598

0.637–4.009

0.318

Previous history of amputation

1.547

0.872–2.745

0.136

1.172

0.649–2.118

0.598

Previous history of EVT

2.230

1.406–3.537

0.001

2.333

1.455–3.740

< 0.001

Critical limb ischemia

1.194

0.839–1.700

0.325

   

HbA1c ≥ 7.0%

1.458

1.001–2.123

0.049

1.473

1.005–2.160

0.047

  1. BMI body mass index, CI confidence interval, EVT endovascular therapy, HbA1c hemoglobin A1c, HR hazard ratio